Nat. Rev. Endocrinol. 8, 326–328 (2012); doi:10.1038/nrendo.2012.64
In the version of this article initially published online and in print there was a mistake in the use of 177Lu-DOTATATE instead of 177Lu-DOTATOC in the first sentence of the third paragraph. The correct sentence should have read "Villard et al.1 compared the efficacy of PRRT with 90Y-DOTATOC to that of PRRT with combined 90Y-DOTATOC and 177Lu-DOTATOC in a large series of patients with metastatic neuroendocrine cancer." The error has been corrected for the HTML and PDF versions of the article.
Additional information
The online version of the original article can be found at 10.1038/nrendo.2012.64
Rights and permissions
About this article
Cite this article
Kwekkeboom, D. Correction: Therapy: Neuroendocrine cancer—are two radionuclides better than one?. Nat Rev Endocrinol 8, 507 (2012). https://doi.org/10.1038/nrendo.2012.130
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2012.130